Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, The Art Of Cure received an FDA Warning Letter on April 15, 2020, regarding drug products. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulation authority, though the specific issuing office is not identified in the metadata provided. To understand the specific compliance issues cited, the complete warning letter would need to be reviewed.